Back to results
US 2022/0017608 A1Published application
Methods of Treating Inflammatory Pain
AssigneeTeva Pharmaceuticals International GmbH
InventorsKristian Todd Poulsen, David Louis Shelton, Joerg Zeller, Ian Machin, Laura Corradini
Life of this patent
Estimating the term…
Abstract
The invention relates to an anti-CGRP antibody for use in the prevention and/or treatment of inflammatory pain and/or symptoms of inflammatory pain, and to a method of treating and/or preventing inflammatory pain and/or symptoms of inflammatory pain using an anti-CGRP antibody.
Claims21
A method for preventing and/or treating inflammatory pain and/or symptoms of inflammatory pain, comprising peripheral administration to the individual of an effective amount of an anti-CGRP antagonist antibody.
-31. (canceled)
Dependencies are inferred from the claim text.